Skip to main content
INVENTURUS KNOWLEDGE SOLUTIONS LIMITED logo

INVENTURUS KNOWLEDGE SOLUTIONS LIMITED — Investor Relations & Filings

Ticker · IKS ISIN · INE115Q01022 LEI · 3358007O1GXF6BHBQX79 BSE.NS Administrative and support service activities
Open in API
Filings indexed 189 across all filing types
Latest filing 2025-01-22 Regulatory Filings
Country IN India
Listing BSE.NS IKS

About INVENTURUS KNOWLEDGE SOLUTIONS LIMITED

https://ikshealth.com/

Inventurus Knowledge Solutions Limited, operating as IKS Health, provides administrative and clinical support solutions for healthcare organizations. The company offers a suite of services designed to manage the business functions of medical practices, including revenue cycle management, clinical documentation, and practice optimization. Key products include virtual scribing services, medical coding, and billing solutions that streamline provider workflows. The company also provides value-based care support and population health management tools to improve clinical outcomes and financial sustainability. By leveraging a combination of technology and domain expertise, the platform addresses administrative burdens, allowing clinicians to focus on patient care while enhancing operational efficiency and data accuracy across the care continuum.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges (BSE and NSE) disclosing the schedule and details of an upcoming Earnings Conference Call for Q3FY25 results. It references Regulation 30 of SEBI Listing Obligations and Disclosure Requirements, which mandates disclosure of material events. The document does not contain any financial results or substantive financial data itself, but rather announces the timing and access details for the earnings call. The document length is short (1756 characters), and it serves as a notification rather than a report or transcript. Therefore, it is best classified as a Regulatory Filing (RNS) because it is a regulatory disclosure announcement about the earnings call, not the call transcript or earnings release itself.
2025-01-22 English
Action(s) taken or orders passed
Regulatory Filings Classification · 95% confidence The document is a disclosure made under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, regarding an order from the Reserve Bank of India. It details a compounding order related to a regulatory contravention involving issuance of partly paid-up shares to non-resident Indians. The document is a formal announcement of this regulatory action and does not contain financial statements, management discussion, or detailed financial data. It is relatively short (3177 characters) and serves as a regulatory announcement rather than a full report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-01-20 English
Board Meeting — Board Meeting Intimation
Regulatory Filings
2025-01-16 English
Board Meeting — Financial Results
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges informing about an upcoming Board Meeting scheduled to consider and approve unaudited financial results for the quarter ended December 31, 2024. It also mentions the closure of the trading window for insiders. The document is short (1750 characters) and serves as an announcement of a future event (Board Meeting) and regulatory compliance under SEBI Listing Regulations. It does not contain any financial data or results itself, nor is it a transcript or report. Therefore, it is best classified as a Regulatory Filing (RNS) since it is a general regulatory announcement and does not fit other specific categories.
2025-01-16 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a certificate under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, for the quarter ended December 31, 2024. It is issued by the Registrar and Share Transfer Agents confirming dematerialisation activities and compliance with regulatory requirements. The document is short (3104 characters) and primarily serves as a compliance certificate rather than a full financial report or detailed filing. It does not contain financial statements or substantive financial data. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for regulatory compliance certificates and miscellaneous filings that do not fit other categories.
2025-01-14 English
Updates
Regulatory Filings Classification · 95% confidence The document is a short notification letter addressed to stock exchanges about a change in the name of the company's Registrar and Share Transfer Agent. It does not contain financial data, management discussion, voting results, or any report content. It is an announcement of a corporate administrative change. The document length is only 1208 characters, indicating it is a brief notice rather than a full report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-01-02 English

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.